IRLAB Therapeutics AB (publ) announced that An van Es-Johansson has elected to leave her assignment as a board member at IRLAB.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.2 SEK | +0.35% | -7.49% | +89.33% |
27/05 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
27/05 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.33% | 69.63M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.75% | 248B | |
-1.84% | 219B | |
+10.83% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- IRLAB Therapeutics AB Announces the Resignation of An Van Es-Johansson as Board Member